{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:27:28Z","timestamp":1782451648211,"version":"3.54.5"},"reference-count":52,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2021A00107"],"award-info":[{"award-number":["CI2021A00107"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["YZ-202041"],"award-info":[{"award-number":["YZ-202041"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundamental Research Expenses for Central-level Public Welfare Research Institutes","award":["CI2021A00107"],"award-info":[{"award-number":["CI2021A00107"]}]},{"name":"Fundamental Research Expenses for Central-level Public Welfare Research Institutes","award":["YZ-202041"],"award-info":[{"award-number":["YZ-202041"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Evidence-Based Complementary and Alternative Medicine"],"published-print":{"date-parts":[[2022,12,17]]},"abstract":"<jats:p>Aims. Abnormal changes in cardiac function have been reported in menopausal women, but there are few clinical studies on this topic. Erxian decoction (EXD) is a classic prescription that is widely used in the treatment of female menopausal diseases. The purpose of this study was to investigate the dynamic evolution of cardiac function and glucose and lipid metabolism in ovariectomized (OVX) rats and the intervention effect of EXD. Materials and Methods. The OVX climacteric rat model was established by bilateral ovariectomy. After successful modeling, the rats were randomly divided into four groups: the sham operation (SHAM) group (equal volumes of purified water), OVX group (equal volumes of purified water), estradiol (E2) group (1.8\u2009\u00d7\u200910\u22124\u2009g\/kg), and EXD group (9\u2009g\/kg). Each group of rats was treated for 16\u2009weeks. At the 4th, 8th, 12th, and 16th weeks after treatment, the cardiac function of the rats in each group was evaluated by ultrasound. The coaxial method was used to measure blood pressure (BP). Serum endothelin-1 (ET-1) and angiotensin-2 (Ang II) levels were determined by the enzyme-linked immunosorbent assay (ELISA). The strip method was used to measure fasting blood glucose (FBG). The serum total cholesterol (TC) and triglyceride (TG) levels of rats were measured with the oxidase method. Direct methods were used to measure serum high-density lipoprotein (HDL-C) and low-density lipoprotein (LDL-C) levels. At week 16 of dosing, serum E2 levels were determined by E2 radioimmunoassay. The myocardium and uterus of the rats in each group were stained with HE (hematoxylin-eosin). The ultrastructure of the rat myocardium was observed by electron microscopy. Results. After the 16th week of treatment, the serum E2 level decreased (<jats:inline-formula>\n                     <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>P<\/a:mi>\n                        <a:mo>&lt;<\/a:mo>\n                        <a:mn>0.05<\/a:mn>\n                     <\/a:math>\n                  <\/jats:inline-formula>), and the uterus was atrophied in OVX rats. The cardiac ejection fraction (EF%) decreased at 4 weeks after treatment, and systolic and diastolic function decreased after 12 weeks. After the 16th week, the EF%, which reflects the \u201cpump\u201d function of the heart, decreased significantly (<jats:inline-formula>\n                     <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mi>P<\/c:mi>\n                        <c:mo>&lt;<\/c:mo>\n                        <c:mn>0.05<\/c:mn>\n                     <\/c:math>\n                  <\/jats:inline-formula> or <jats:inline-formula>\n                     <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mi>P<\/e:mi>\n                        <e:mo>&lt;<\/e:mo>\n                        <e:mn>0.01<\/e:mn>\n                     <\/e:math>\n                  <\/jats:inline-formula>). At the 4th, 8th, 12th, and 16th weeks of treatment, the systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean pressure (MBP) of the rats in the OVX group increased with time (<jats:inline-formula>\n                     <g:math xmlns:g=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\">\n                        <g:mi>P<\/g:mi>\n                        <g:mo>&lt;<\/g:mo>\n                        <g:mn>0.05<\/g:mn>\n                     <\/g:math>\n                  <\/jats:inline-formula> or <jats:inline-formula>\n                     <i:math xmlns:i=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M5\">\n                        <i:mi>P<\/i:mi>\n                        <i:mo>&lt;<\/i:mo>\n                        <i:mn>0.01<\/i:mn>\n                     <\/i:math>\n                  <\/jats:inline-formula>). The serum ET-1 and Ang II levels of rats in the OVX group increased (<jats:inline-formula>\n                     <k:math xmlns:k=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M6\">\n                        <k:mi>P<\/k:mi>\n                        <k:mo>&lt;<\/k:mo>\n                        <k:mn>0.05<\/k:mn>\n                     <\/k:math>\n                  <\/jats:inline-formula> or <jats:inline-formula>\n                     <m:math xmlns:m=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M7\">\n                        <m:mi>P<\/m:mi>\n                        <m:mo>&lt;<\/m:mo>\n                        <m:mn>0.01<\/m:mn>\n                     <\/m:math>\n                  <\/jats:inline-formula>). In the OVX group, FBG was increased (<jats:inline-formula>\n                     <o:math xmlns:o=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M8\">\n                        <o:mi>P<\/o:mi>\n                        <o:mo>&lt;<\/o:mo>\n                        <o:mn>0.05<\/o:mn>\n                     <\/o:math>\n                  <\/jats:inline-formula> or <jats:inline-formula>\n                     <q:math xmlns:q=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M9\">\n                        <q:mi>P<\/q:mi>\n                        <q:mo>&lt;<\/q:mo>\n                        <q:mn>0.01<\/q:mn>\n                     <\/q:math>\n                  <\/jats:inline-formula>), and blood lipids, especially LDL-C, were significantly increased (<jats:inline-formula>\n                     <s:math xmlns:s=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M10\">\n                        <s:mi>P<\/s:mi>\n                        <s:mo>&lt;<\/s:mo>\n                        <s:mn>0.05<\/s:mn>\n                     <\/s:math>\n                  <\/jats:inline-formula> or <jats:inline-formula>\n                     <u:math xmlns:u=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M11\">\n                        <u:mi>P<\/u:mi>\n                        <u:mo>&lt;<\/u:mo>\n                        <u:mn>0.01<\/u:mn>\n                     <\/u:math>\n                  <\/jats:inline-formula>). After the 16th week of treatment, the myocardial tissue of OVX rats showed obvious pathological changes. EXD significantly increased serum E2 levels (<jats:inline-formula>\n                     <w:math xmlns:w=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M12\">\n                        <w:mi>P<\/w:mi>\n                        <w:mo>&lt;<\/w:mo>\n                        <w:mn>0.01<\/w:mn>\n                     <\/w:math>\n                  <\/jats:inline-formula>), decreased ET-1 and Ang II levels (<jats:inline-formula>\n                     <y:math xmlns:y=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M13\">\n                        <y:mi>P<\/y:mi>\n                        <y:mo>&lt;<\/y:mo>\n                        <y:mn>0.01<\/y:mn>\n                     <\/y:math>\n                  <\/jats:inline-formula>), reduced the cardiac function risk factors BP, FBG, and blood lipids, and significantly improved cardiac function and structural changes in OVX rats (<jats:inline-formula>\n                     <ab:math xmlns:ab=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M14\">\n                        <ab:mi>P<\/ab:mi>\n                        <ab:mo>&lt;<\/ab:mo>\n                        <ab:mn>0.05<\/ab:mn>\n                     <\/ab:math>\n                  <\/jats:inline-formula> or <jats:inline-formula>\n                     <cb:math xmlns:cb=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M15\">\n                        <cb:mi>P<\/cb:mi>\n                        <cb:mo>&lt;<\/cb:mo>\n                        <cb:mn>0.01<\/cb:mn>\n                     <\/cb:math>\n                  <\/jats:inline-formula>). Conclusions. EXD can improve abnormal cardiac structure and function in OVX rats.<\/jats:p>","DOI":"10.1155\/2022\/8090868","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T19:50:05Z","timestamp":1671306605000},"page":"1-14","source":"Crossref","is-referenced-by-count":4,"title":["Dynamic Evolution of Cardiac Function and Glucose and Lipid Metabolism in Ovariectomized Rats and the Intervention Effect of Erxian Decoction"],"prefix":"10.1155","volume":"2022","author":[{"given":"Yuhan","family":"Wang","sequence":"first","affiliation":[{"name":"Institute of Basic Theory for Chinese Medicine, Chinese Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Jiang","sequence":"additional","affiliation":[{"name":"Institute of Basic Research in Clinical Medicine, Chinese Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[{"name":"Institute of Basic Theory for Chinese Medicine, Chinese Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Basic Theory for Chinese Medicine, Chinese Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Basic Theory for Chinese Medicine, Chinese Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Basic Theory for Chinese Medicine, Chinese Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8626-8611","authenticated-orcid":true,"given":"Zhiguo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Basic Theory for Chinese Medicine, Chinese Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7920-5778","authenticated-orcid":true,"given":"Yanjing","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Basic Theory for Chinese Medicine, Chinese Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","volume-title":"Cardiovascular Diseases (CVDs)","author":"WHO (World Health Organ)","year":"2017"},{"key":"2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev-pathmechdis-012419-032544","article-title":"Cardiovascular disease, aging, and clonal hematopoiesis","volume":"15","author":"M. A. Evans","year":"2020","journal-title":"Annual Review of Pathology"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-2667(19)30184-7"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13480"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00919"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.12.018"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2021.03.009"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1007\/bf02984679"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.3390\/nu12010202"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.033"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10195-6"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1097\/hjh.0000000000001632"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.4103\/0976-7800.195695"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0000000000001403"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2015.1130694"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.03.007"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e318280589a"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.112.103218"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2016.01.009"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13812"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e31827cd3dd"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2016.11.018"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2009.02.034"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-018-2311-9"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-77932-4_27"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-011-0892-8"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000509"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.2174\/1381612827666210927162612"},{"key":"29","first-page":"291","volume-title":"Sex Specific Mechanisms of Cardiac Hypertrophy and Heart failure","author":"R. Z. Vera","year":"2019"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.12.008"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2015.10.021"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2010.03.027"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2018.01.006"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01042.2015"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2007.08.009"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24203700"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s168946"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2017.11.035"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-019-09803-3"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2015.01.001"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-012-0319-y"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-7061(00)01257-7"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.3109\/10641963.2015.1116550"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2013.10.002"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00045.2020"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2012.01.007"},{"issue":"08","key":"47","first-page":"170","article-title":"Clinical effect of Erxian Decoction in adjuvant treatment of post- menopausal women with hypertension and its effect on estrogen and Kup-perman score","volume":"17","author":"X. Xiang","year":"2020","journal-title":"China Medical Herald"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.116.005032"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05637-7"},{"key":"50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2019.02.012"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110675"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.27282\/d.cnki.gsdzu.2021.000818"}],"container-title":["Evidence-Based Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2022\/8090868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2022\/8090868.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2022\/8090868.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T19:50:13Z","timestamp":1671306613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/ecam\/2022\/8090868\/"}},"subtitle":[],"editor":[{"given":"Rajeev K.","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":52,"alternative-id":["8090868","8090868"],"URL":"https:\/\/doi.org\/10.1155\/2022\/8090868","relation":{},"ISSN":["1741-4288","1741-427X"],"issn-type":[{"value":"1741-4288","type":"electronic"},{"value":"1741-427X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,17]]}}}